Knowing the organs and/or size of vessels affected by drug-induced vasculitis can help pinpoint the problematic agent, which is the first step in treating the disease.
Read MoreVitamin D: A Metabolic Bone Disease Perspective
Clinicians concerned about patients’ Vitamin D levels should consider a wide range of factors involved, as well as conditions that might influence whether supplements are needed.
Case Study: Making the VEXAS Diagnosis (Video)
At first, steroids relieved the 71-year-old man’s, but a new one appeared after the dose was tapered.
What Long COVID Means for Rheumatologists (Video)
Doctors who work at the intersection of infectious and immunologic diseases have much to contribute to the understanding of and response to long COVID.
Case Report: Recurrent Polymyalgia Rheumatica (Video)
A 74-year-old patient had recurring symptoms of stiffness, weakness and fatigue and required higher doses of prednisone to achieve relief. Alexandra Villa-Forte, MD, presents a case of polymyalgia rheumatica.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Multidisciplinary Management in Scleroderma‑Associated Interstitial Lung Disease
Timely detection and treatment benefits patients with scleroderma‑associated interstitial lung disease and the physicians who treat them.
Preconception Planning is Essential for Patients With Lupus
It’s especially important for patients with systemic lupus erythematosus to be optimized for pregnancy.
Weekly Case Conferences Make for Engaged Learning
Rheumatology fellows at Cleveland Clinic organize a once-a-week case discussion to hone skills clinical reasoning and be posed to a wide variety of diseases and disorders within a complex medical specialty.
Case Study: TNF Inhibitor Plays Role in Unraveling a Challenging Diagnosis
A patient with a long history of inflammation in his right hand seemed an unlikely candidate for the infection that was finally diagnosed.
Optimal Management of High Risk Immunocompromised Patients in the COVID-19 Era
Rheumatologists are called upon to know which patients are more vulnerable to COVID-19, to counsel on risk, and to recommend vaccination and PrEP when appropriate.
Real World Experience with Tixagevimab/Cilgavimab in B-Cell-Depleted Patients
Early results were positive in a study of the preventive treatment of COVID-19 with xagevimab/cilgavimab for patients who were unlikely to respond sufficiently or at all to vaccination.